Related references
Note: Only part of the references are listed.Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae
Allison E. B. Turner et al.
SYNTHETIC AND SYSTEMS BIOTECHNOLOGY (2017)
Impact of the Conjugation Method on the Immunogenicity of Streptococcus pneumoniae Serotype 19F Polysaccharide in Conjugate Vaccines
Jan Poolman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Monitoring activation sites on polysaccharides by GC-MS
John S. Kim et al.
ANALYTICAL BIOCHEMISTRY (2006)
Determination of saccharide content in pneumococcal polysaccharides and conjugate vaccines by GG-MSD
JS Kim et al.
ANALYTICAL BIOCHEMISTRY (2005)
A microtiter modification of the anthrone-sulfuric acid colorimetric assay for glucose-based carbohydrates
A Laurentin et al.
ANALYTICAL BIOCHEMISTRY (2003)
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
SB Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Efficacy of a pneumococcal conjugate vaccine against acute otitis media
J Eskola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides
DE Shafer et al.
VACCINE (2000)
Periodate oxidation of crystalline cellulose
UJ Kim et al.
BIOMACROMOLECULES (2000)
Share Paper
